Dipeptidyl Peptidase-4 Inhibitors Have Protective Effect on Cognitive Impairment in Aged Diabetic Patients With Mild Cognitive Impairment

Hyperglycemia-induced Oxidative Stress and its Role in Diabetes Mellitus Related Cardiovascular Diseases

(2013) Teresa Fiorentino et al.   CURRENT PHARMACEUTICAL DESIGN

Glucagon-Like Peptide 1 Reduces Endothelial Dysfunction, Inflammation, and Oxidative Stress Induced by Both Hyperglycemia and Hypoglycemia in Type 1 Diabetes

(2013) A. Ceriello et al.   DIABETES CARE

Diagnosing Mild Cognitive Impairment (MCI) in clinical trials: a systematic review

(2013) Blossom Christa Maree Stephan et al.   BMJ Open

Dipeptidyl Peptidase-4 Inhibitors in the Elderly: More Benefits or Risks?

(2012) Giuseppe Paolisso et al.   ADVANCES IN THERAPY

Update on incretin hormones

(2012) Liza K. Phillips et al.   Annals of the New York Academy of Sciences

Diabetes, Glucose Control, and 9-Year Cognitive Decline Among Older Adults Without Dementia

(2012) Kristine Yaffe et al.   ARCHIVES OF NEUROLOGY

Comparison of vildagliptin twice daily vs. sitagliptin once daily using continuous glucose monitoring (CGM): Crossover pilot study (J-VICTORIA study)

(2012) Masaya Sakamoto et al.   Cardiovascular Diabetology

Continuous glucose profiles with vildagliptin versus sitagliptin in add-on to metformin: Results from the randomized Optima study

(2012) B. Guerci et al.   DIABETES & METABOLISM

Reduction of Oxidative Stress and Inflammation by Blunting Daily Acute Glucose Fluctuations in Patients With Type 2 Diabetes: Role of dipeptidyl peptidase-IV inhibition

(2012) M. R. Rizzo et al.   DIABETES CARE

Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies

(2012) G. Cheng et al.   INTERNAL MEDICINE JOURNAL

Diabetes in Older Adults: A Consensus Report

(2012) M. Sue Kirkman et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Diabetes Mellitus in Older People: Position Statement on behalf of the International Association of Gerontology and Geriatrics (IAGG), the European Diabetes Working Party for Older People (EDWPOP), and the International Task Force of Experts in Diabetes

(2012) Alan Sinclair et al.   Journal of the American Medical Directors Association

Comparative Efficacy of Vildagliptin and Sitagliptin in Japanese Patients with Type 2 Diabetes Mellitus

(2011) James E. Signorovitch et al.   CLINICAL DRUG INVESTIGATION

Hypoglycaemia and dementia in diabetic patients

(2011) B. Bauduceau et al.   DIABETES & METABOLISM

The Contribution of Glucose Variability to Asymptomatic Hypoglycemia in Persons with Type 2 Diabetes

(2011) Louis Monnier et al.   Diabetes Technology & Therapeutics

Normal Reference Range for Mean Tissue Glucose and Glycemic Variability Derived from Continuous Glucose Monitoring for Subjects Without Diabetes in Different Ethnic Groups

(2011) Nathan R. Hill et al.   Diabetes Technology & Therapeutics

Glucagon-Like Peptide-1, Diabetes, and Cognitive Decline: Possible Pathophysiological Links and Therapeutic Opportunities

(2011) Enrico Mossello et al.   Experimental Diabetes Research

Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy

(2011) Lenore J Launer et al.   LANCET NEUROLOGY

Relationships Between Daily Acute Glucose Fluctuations and Cognitive Performance Among Aged Type 2 Diabetic Patients

(2010) M. R. Rizzo et al.   DIABETES CARE

Rosiglitazone and Cognitive Stability in Older Individuals With Type 2 Diabetes and Mild Cognitive Impairment

(2010) A. M. Abbatecola et al.   DIABETES CARE

Cognitive dysfunction in patients with type 2 diabetes

(2010) Yael D. Reijmer et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Proteomics Reveals Novel Oxidative and Glycolytic Mechanisms in Type 1 Diabetic Patients' Skin Which Are Normalized by Kidney-Pancreas Transplantation

(2010) Franco Folli et al.   PLoS One

Neuroprotection of geniposide against hydrogen peroxide induced PC12 cells injury: involvement of PI3 kinase signal pathway

(2009) Jian-hui Liu et al.   ACTA PHARMACOLOGICA SINICA

Relationship Between Baseline Glycemic Control and Cognitive Function in Individuals With Type 2 Diabetes and Other Cardiovascular Risk Factors: The Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes (ACCORD-MIND) trial

(2009) T. Cukierman-Yaffe et al.   DIABETES CARE

Cognitive decline associated with dementia and type 2 diabetes: the interplay of risk factors

(2009) C. Messier et al.   DIABETOLOGIA

Effects of vildagliptin twice daily vs. sitagliptin once daily on 24-hour acute glucose fluctuations

(2009) Raffaele Marfella et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Association of Duration and Severity of Diabetes Mellitus With Mild Cognitive Impairment

(2008) Rosebud O. Roberts et al.   ARCHIVES OF NEUROLOGY

Diabetes as a Risk Factor for Cognitive Decline in Older Patients

(2008) S. Maggi et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Hyperglycaemia as a determinant of cognitive decline in patients with type 1 diabetes

(2008) Alette M. Wessels et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

A meta-analysis of the accuracy of the mini-mental state examination in the detection of dementia and mild cognitive impairment

(2008) Alex J. Mitchell   JOURNAL OF PSYCHIATRIC RESEARCH

Glucagon-like Peptide-1 (GLP-1) Diminishes Neuronal Degeneration and Death Caused by NGF Deprivation by Suppressing Bim Induction

(2008) Subhas C. Biswas et al.   NEUROCHEMICAL RESEARCH